Patient |
| Gene | Chromosome location | Transcript exon | Nucleotide Amino acid | Homozygous/Heterozygous | Normal human frequency | Prediction | Pathogenicity analysis | Genetic pattern | Disease/Phenotype | Variation source |
Case A | 1. Genetic variants with highly correlated clinical phenotypes and well-documented pathogenicity | not found | ||||||||||
2. Large sample data support susceptible sites | ATP7A | chrX: 7730 1954 | NM_ 00005 2; exon23 | c.4390A > G (p.I1464V) | hemi | 0.0166 | - | - | 1. XLR 2. XLR 3. XLR | 1. Menkes disease 2. Occipital Angle syndrome 3. X-linked distal spinal muscular atrophy type 3 |
| |
3. Other mutations with insufficient pathogenic evidence need to be further combined with clinical analysis, and the possibility of pathogenesis cannot be ruled out | GABR G2 | chr5: 1615 24870 | NM_ 0008 16; exon4 | c.548 + 6C > A (splicing) | het | 5.454E−5 | - | Uncertain | 1. AD 2. AD 3. AD | 1. Generalized epilepsy with febrile convulsion plus type 3 2. Familial febrile epilepsy 8 3. Epileptic encephalopathy in early infancy 74 | Mother | |
Case B | 1. Genetic variants with highly correlated clinical phenotypes and well-documented pathogenicity | not found | ||||||||||
2. Other mutations with insufficient pathogenic evidence need to be further combined with clinical analysis, and the possibility of pathogenesis cannot be ruled out | SCN9A | chr2: 1670 85398 | NM_ 0029 77; exon22 | c.3976A > C (p.I1326L) | het | 0.00090 | D | Uncertain | 1. AD 2. AD 3. AR 4. AD 5. AD | 1. Systemic epilepsy with febrile convulsion type 7 2. Primary erythromelalgia 3. Congenital insensitivity to pain 4. Dravet syndrome, repair 5. Paroxysmal pain | Mother | |
3. Other variation information | MYH11 | Chr16: 15818116 | NM_ 0024 74; exon31 | c.4267A > C (p.N1423H) | het | - | B | Uncertain | AD | Familial thoracic aortic aneurysm and aortic dissection type 4 |
| |
CAD | Chr2: 27456870 | NM_ 0043 41; exon22 | c.3400-6C > T (splicing) | het | 0.00004 | - | Uncertain | AR | Congenital glycosylation disease Iz type |
| ||
ARV1 | Chr1: 231131724 | NM_ 0227 86; exon4 | c.667A > G (p.I223V) | het | 0 | B | Uncertain | AR | Early infantile epileptic encephalopathy, type 38 |
| ||
Case C | 1. Genetic variants with highly correlated clinical phenotypes and well-documented pathogenicity | not found | ||||||||||
2. Other mutations with insufficient pathogenic evidence need to be further combined with clinical analysis, and the possibility of pathogenesis cannot be ruled out | SPTAN1 | chr9: 131394 760- 131394760 | NM_0011 30438; exon54 | c.7010_ 7011ins TAAG (p.F2337fs) | het | 0.00060 | - | Uncertain | AD | Epileptic encephalopathy of early childhood type 5 | Father | |
3. Other variation information | RELN | chr7: 10312 4262 | NM_0050 45; exon62 | c.10019C > T (p.S3340L) | het | 0 | B | Uncertain | 1. AR 2. AD | 1. Anencephaly 2. Familial temporal lobe epilepsy 7 |
| |
MTOR | chr1: 11194 424 | NM_0049 58; exon37 | c.5230C > T (p.H1744Y) | het | 0.00020 | B | Uncertain | AD | Smith-Kingsmore syndrome |
| ||
Case D | 1. Genetic variants with highly correlated clinical phenotypes and well-documented pathogenicity | not found | ||||||||||
2. Other variation information | ARHG EF15 | chr17: 82163 54 | NM_1737 28; exon3 | c.716G > A (p.R239H) | het | 0.0000084 | B | Uncertain | - | Epileptic encephalopathy |
| |
| MAGI2 | chr7: 786365 30-78636531 | NM_0123 01; exon2 | c.302-9delT (splicing) | het | 0.0039 | - | Uncertain | AR | Nephrotic syndrome type 15 |
| |
Case E | Genetic variants with highly correlated clinical phenotypes and well-documented pathogenicity | not found | ||||||||||
The specific list of tested genes is shown in the attachment. |